Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Autoimmune Disorders

  Free Subscription


Articles published in Kidney Int

Retrieve available abstracts of 53 articles:
HTML format
Text format



Single Articles


    September 2017
  1. SINGH G, Bhardwaj S, Singh L, Sinha A, et al
    Proliferative glomerulonephritis with monotypic IgA-kappa deposits in a 10-year-old.
    Kidney Int. 2017;92:765-766.
    PubMed     Text format    


    August 2017
  2. DE FIJTER JW
    Recurrence of glomerulonephritis: an underestimated and unmet medical need.
    Kidney Int. 2017;92:294-296.
    PubMed     Text format     Abstract available


  3. FLOEGE J
    Mucosal corticosteroid therapy of IgA nephropathy.
    Kidney Int. 2017;92:278-280.
    PubMed     Text format     Abstract available


    July 2017
  4. DAI Y, Chen A, Liu R, Gu L, et al
    Retinoic acid improves nephrotoxic serum-induced glomerulonephritis through activation of podocyte retinoic acid receptor alpha.
    Kidney Int. 2017 Jul 27. pii: S0085-2538(17)30321.
    PubMed     Text format     Abstract available


  5. BROCKLEBANK V, Johnson S, Sheerin TP, Marks SD, et al
    Factor H autoantibody is associated with atypical hemolytic uremic syndrome in children in the United Kingdom and Ireland.
    Kidney Int. 2017 Jul 24. pii: S0085-2538(17)30323.
    PubMed     Text format     Abstract available


  6. TURNER-STOKES T, Wilson HR, Morreale M, Nunes A, et al
    Positive antineutrophil cytoplasmic antibody serology in patients with lupus nephritis is associated with distinct histopathologic features on renal biopsy.
    Kidney Int. 2017 Jul 24. pii: S0085-2538(17)30324.
    PubMed     Text format     Abstract available


  7. BOJIC M, Kozakowski N, Becede M, Kerschbaumer A, et al
    The Case | Myeloid bodies in the kidney biopsy of a patient with systemic lupus erythematosus.
    Kidney Int. 2017;92:271-272.
    PubMed     Text format    


    June 2017
  8. MEDJERAL-THOMAS NR, Lomax-Browne HJ, Beckwith H, Willicombe M, et al
    Circulating complement factor H-related proteins 1 and 5 correlate with disease activity in IgA nephropathy.
    Kidney Int. 2017 Jun 30. pii: S0085-2538(17)30256.
    PubMed     Text format     Abstract available


  9. TORTAJADA A, Gutierrez E, Goicoechea de Jorge E, Anter J, et al
    Elevated factor H-related protein 1 and factor H pathogenic variants decrease complement regulation in IgA nephropathy.
    Kidney Int. 2017 Jun 18. pii: S0085-2538(17)30254.
    PubMed     Text format     Abstract available


  10. ALLEN PJ, Chadban SJ, Craig JC, Lim WH, et al
    Recurrent glomerulonephritis after kidney transplantation: risk factors and allograft outcomes.
    Kidney Int. 2017 Jun 7. pii: S0085-2538(17)30208.
    PubMed     Text format     Abstract available


  11. VAN LAECKE S, Van Biesen W
    Severe hypertension with renal thrombotic microangiopathy: what happened to the usual suspect?
    Kidney Int. 2017;91:1271-1274.
    PubMed     Text format     Abstract available


    March 2017
  12. TRIMARCHI H, Barratt J, Cattran DC, Cook HT, et al
    Oxford Classification of IgA nephropathy 2016-the role of crescentic lesions: an update from the IgA Nephropathy Classification Working Group.
    Kidney Int. 2017 Mar 21. pii: S0085-2538(17)30101.
    PubMed     Text format     Abstract available


  13. ROSENZWAJG M, Languille E, Debiec H, Hygino J, et al
    B- and T-cell subpopulations in patients with severe idiopathic membranous nephropathy may predict an early response to rituximab.
    Kidney Int. 2017 Mar 15. pii: S0085-2538(17)30039.
    PubMed     Text format     Abstract available


    January 2017
  14. LUQUE Y, Cathelin D, Vandermeersch S, Xu X, et al
    Glomerular common gamma chain confers B- and T-cell-independent protection against glomerulonephritis.
    Kidney Int. 2017 Jan 19. pii: S0085-2538(16)30653.
    PubMed     Text format     Abstract available


  15. CATTRAN DC, Brenchley PE
    Membranous nephropathy: integrating basic science into improved clinical management.
    Kidney Int. 2017 Jan 5. pii: S0085-2538(16)30617.
    PubMed     Text format     Abstract available


    November 2016
  16. BELLUR SS, Lepeytre F, Vorobyeva O, Troyanov S, et al
    Evidence from the Oxford Classification cohort supports the clinical value of subclassification of focal segmental glomerulosclerosis in IgA nephropathy.
    Kidney Int. 2016 Nov 30. pii: S0085-2538(16)30562.
    PubMed     Text format     Abstract available


  17. YAN JJ, Lee JG, Jang JY, Koo TY, et al
    IL-2/anti-IL-2 complexes ameliorate lupus nephritis by expansion of CD4+CD25+Foxp3+ regulatory T cells.
    Kidney Int. 2016 Nov 30. pii: S0085-2538(16)30551.
    PubMed     Text format     Abstract available


  18. COSIO FG, Cattran DC
    Recent advances in our understanding of recurrent primary glomerulonephritis after kidney transplantation.
    Kidney Int. 2016 Nov 9. pii: S0085-2538(16)30484.
    PubMed     Text format     Abstract available


    October 2016
  19. PANG Y, Tan Y, Li Y, Zhang J, et al
    Serum A08 C1q antibodies are associated with disease activity and prognosis in Chinese patients with lupus nephritis.
    Kidney Int. 2016 Oct 10. pii: S0085-2538(16)30437.
    PubMed     Text format     Abstract available


  20. CATTRAN DC
    Toward quantitating the burden of glomerulonephritis in the United States.
    Kidney Int. 2016;90:732-4.
    PubMed     Text format     Abstract available


    August 2016
  21. BIENAIME F, Legendre C, Terzi F, Canaud G, et al
    Antiphospholipid syndrome and kidney disease.
    Kidney Int. 2016 Aug 20. pii: S0085-2538(16)30317.
    PubMed     Text format     Abstract available


  22. LEVENTHAL JS, Ross MJ
    LAPping up dead cells to prevent lupus nephritis: a novel role for noncanonical autophagy in autoimmunity.
    Kidney Int. 2016;90:238-9.
    PubMed     Text format     Abstract available


    July 2016
  23. WETMORE JB, Guo H, Liu J, Collins AJ, et al
    The incidence, prevalence, and outcomes of glomerulonephritis derived from a large retrospective analysis.
    Kidney Int. 2016 Jul 14. pii: S0085-2538(16)30211.
    PubMed     Text format     Abstract available


  24. VANKALAKUNTI M, Vasavi B, Anitha A
    Intravascular large B-cell lymphoma: masquerade as membranoproliferative glomerulonephritis.
    Kidney Int. 2016;90:231-2.
    PubMed     Text format    


  25. ANDERS HJ, Rovin B
    A pathophysiology-based approach to the diagnosis and treatment of lupus nephritis.
    Kidney Int. 2016 Jul 1. pii: S0085-2538(16)30208.
    PubMed     Text format     Abstract available


    June 2016
  26. HOOVER PJ, Costenbader KH
    Insights into the epidemiology and management of lupus nephritis from the US rheumatologist's perspective.
    Kidney Int. 2016 Jun 22. pii: S0085-2538(16)30171.
    PubMed     Text format     Abstract available


  27. RYAN MS, Satoskar AA, Nadasdy GM, Brodsky SV, et al
    Phospholipase A2 receptor staining is absent in many kidney biopsies with early-stage membranous glomerulonephritis.
    Kidney Int. 2016;89:1402-3.
    PubMed     Text format    


  28. RAMACHANDRAN R, Kumar V, Jha V
    Cyclical cyclophosphamide and steroids is effective in resistant or relapsing nephrotic syndrome due to M-type phospholipase A2 receptor-related membranous nephropathy after tacrolimus therapy.
    Kidney Int. 2016;89:1401-2.
    PubMed     Text format    


  29. GUERRY MJ, Vanhille P, Ronco P, Debiec H, et al
    Serum anti-PLA2R antibodies may be present before clinical manifestations of membranous nephropathy.
    Kidney Int. 2016;89:1399.
    PubMed     Text format    


    May 2016
  30. DRAGUN D, Catar R, Philippe A
    Non-HLA antibodies against endothelial targets bridging allo- and autoimmunity.
    Kidney Int. 2016 May 14. pii: S0085-2538(16)30071.
    PubMed     Text format     Abstract available


  31. HOFSTRA JM, Wetzels JF
    Should aspirin be used for primary prevention of thrombotic events in patients with membranous nephropathy?
    Kidney Int. 2016;89:981-3.
    PubMed     Text format     Abstract available


    April 2016
  32. ZHANG L, Lee G, Liu X, Pascoe EM, et al
    Long-term outcomes of end-stage kidney disease for patients with lupus nephritis.
    Kidney Int. 2016 Apr 8. pii: S0085-2538(16)00363.
    PubMed     Text format     Abstract available


  33. PICCOLI GB, Capobianco M, Vigotti FN, Naretto C, et al
    The Case | The young philosopher with multiple sclerosis and proteinuria.
    Kidney Int. 2016;89:961-3.
    PubMed     Text format    


  34. NEVES PD, Bezerra KS, Silveira MA, Yu L, et al
    Schistosoma mansoni and membranous nephropathy.
    Kidney Int. 2016;89:959.
    PubMed     Text format    


  35. ROSALES IA, Colvin RB
    Glomerular disease with idiopathic linear immunoglobulin deposition: a rose by any other name would be atypical.
    Kidney Int. 2016;89:750-2.
    PubMed     Text format     Abstract available


  36. NASR SH, Collins AB, Alexander MP, Schraith DF, et al
    The clinicopathologic characteristics and outcome of atypical anti-glomerular basement membrane nephritis.
    Kidney Int. 2016;89:897-908.
    PubMed     Text format     Abstract available


    February 2016
  37. LEE T, Derebail VK, Kshirsagar AV, Chung Y, et al
    Patients with primary membranous nephropathy are at high risk of cardiovascular events.
    Kidney Int. 2016 Feb 26. pii: S0085-2538(16)00275.
    PubMed     Text format     Abstract available


  38. NOWAK N, Skupien J, Niewczas MA, Yamanouchi M, et al
    Increased plasma kidney injury molecule-1 suggests early progressive renal decline in non-proteinuric patients with type 1 diabetes.
    Kidney Int. 2016;89:459-67.
    PubMed     Text format     Abstract available


    January 2016
  39. PRUTHI R, McClure M, Casula A, Roderick PJ, et al
    Long-term graft outcomes and patient survival are lower posttransplant in patients with a primary renal diagnosis of glomerulonephritis.
    Kidney Int. 2016 Jan 21. pii: S0085-2538(15)00176.
    PubMed     Text format     Abstract available


  40. HOUSSIAU FA
    Moving East: the Euro-Lupus Nephritis regimen in Asia.
    Kidney Int. 2016;89:25-7.
    PubMed     Text format     Abstract available


  41. FLOEGE J
    Prognostic assessment of IgA nephropathy: how much does histology add?
    Kidney Int. 2016;89:19-21.
    PubMed     Text format     Abstract available


  42. FLOEGE J, Rauen T
    Immunosuppression in IgA nephropathy: how certain are we?
    Kidney Int. 2016;89:9-11.
    PubMed     Text format     Abstract available


  43. BARBOUR SJ, Espino-Hernandez G, Reich HN, Coppo R, et al
    The MEST score provides earlier risk prediction in lgA nephropathy.
    Kidney Int. 2016;89:167-75.
    PubMed     Text format     Abstract available


  44. KLUGER MA, Melderis S, Nosko A, Goerke B, et al
    Treg17 cells are programmed by Stat3 to suppress Th17 responses in systemic lupus.
    Kidney Int. 2016;89:158-66.
    PubMed     Text format     Abstract available


  45. IRIFUKU T, Doi S, Sasaki K, Doi T, et al
    Inhibition of H3K9 histone methyltransferase G9a attenuates renal fibrosis and retains klotho expression.
    Kidney Int. 2016;89:147-57.
    PubMed     Text format     Abstract available


  46. SELEZNIK G, Seeger H, Bauer J, Fu K, et al
    The lymphotoxin beta receptor is a potential therapeutic target in renal inflammation.
    Kidney Int. 2016;89:113-26.
    PubMed     Text format     Abstract available


    December 2015
  47. SETHI S, Fervenza FC, Smith RJ, Haas M, et al
    Overlap of ultrastructural findings in C3 glomerulonephritis and dense deposit disease.
    Kidney Int. 2015;88:1449-1450.
    PubMed     Text format    


    November 2015
  48. SERINO G, Pesce F, Sallustio F, De Palma G, et al
    In a retrospective international study, circulating miR-148b and let-7b were found to be serum markers for detecting primary IgA nephropathy.
    Kidney Int. 2015 Nov 18. doi: 10.1038/ki.2015.
    PubMed     Text format     Abstract available


  49. RAMACHANDRAN R, Kumar V, Nada R, Jha V, et al
    Serial monitoring of anti-PLAR in initial PLAR-negative patients with primary membranous nephropathy.
    Kidney Int. 2015;88:1198-1199.
    PubMed     Text format    


  50. COUSER WG, Johnson RJ
    What is myeloperoxidase doing in ANCA-associated glomerulonephritis?
    Kidney Int. 2015;88:938-940.
    PubMed     Text format     Abstract available


    April 2015
  51. CROFT AP, Smith SW, Carr S, Youssouf S, et al
    Successful outcome of pregnancy in patients with anti-neutrophil cytoplasm antibody-associated small vessel vasculitis.
    Kidney Int. 2015;87:807-11.
    PubMed     Text format     Abstract available


    March 2015
  52. SCHREIBER A, Schindler R, Adcock Funk DM, Kahl A, et al
    The Case | A 48-year-old man with pulmonary-renal syndrome.
    Kidney Int. 2015;87:667-8.
    PubMed     Text format    


  53. SPINALE JM, Mariani LH, Kapoor S, Zhang J, et al
    A reassessment of soluble urokinase-type plasminogen activator receptor in glomerular disease.
    Kidney Int. 2015;87:564-74.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Autoimmune Disorders is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: